Claire Madden Smith

Claire has more than 20 years experience in the pharmaceutical sector, Claire was an Executive Director at Molecular Profiles Ltd and served as Senior Vice President at Juniper Pharma Services Ltd at the time of its sale to Catalent for $140m in 2018.

As a senior executive, Claire has proven success in delivering growth, building from a small spin out to an organisation with over 200 employees. She currently acts as an independent consultant to the investment community and to pharmaceutical companies, providing support on growth, investment strategies and due diligence.